Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Immunology and Cell Biology is Scopus-indexed (Q3, CiteScore 4.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley & Sons Inc..
Checked against the index lists dated .
ISSN 0818-9641Verify ISSN ↗1440-1711Verify ISSN ↗
Publisher: John Wiley & Sons Inc.
Cost to publish: About US$3,750 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 120 / 234 | 48th | Q3 |
| Immunology | 132 / 243 | 45th | Q3 |
| Cell Biology | 185 / 289 | 35th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1987–present, best quartile Q3, CiteScore 4.7.
Immunology and Cell Biology is Q3 in Immunology and Allergy (rank 120 of 234), Q3 in Immunology (rank 132 of 243) and Q3 in Cell Biology (rank 185 of 289), by CiteScore 2025.
Immunology and Cell Biology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.7, which places it in quartile Q3 at the 48th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.079, quartile Q2, with an H-index of 126.
The publisher lists an article processing charge of about US$3,750 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Immunology and Cell Biology is published by John Wiley & Sons Inc. Its print ISSN is 0818-9641 and its online ISSN is 1440-1711.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Immunology and Cell Biology has an h-index of 152 and a 2-year mean of 1.98 citations per paper (OpenAlex). Its Scopus CiteScore is 4.7, quartile Q3. On 2-year citations it ranks #120 of 231 Scopus journals in Immunology and Allergy.
Immunology and Cell Biology published 106 papers in 2025; its busiest recent year was 2018 with 140. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from Australia (45.7%), China (11.2%) and United Kingdom (8.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (0.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.